{"version":"1.0","provider_name":"Voisins de l'UE","provider_url":"https:\/\/www.eumedbridge.eu\/fr\/","author_name":"Nidhal Battikh","author_url":"https:\/\/www.eumedbridge.eu\/fr\/author\/nidhal_admin\/","title":"Deuxi\u00e8me bulletin d\u2019information de CREACT4MED - Voisins de l'UE","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"8N1oBnzZf0\"><a href=\"https:\/\/www.eumedbridge.eu\/fr\/publication\/deuxieme-bulletin-dinformation-de-creact4med\/\">Deuxi\u00e8me bulletin d\u2019information de CREACT4MED<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.eumedbridge.eu\/fr\/publication\/deuxieme-bulletin-dinformation-de-creact4med\/embed\/#?secret=8N1oBnzZf0\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Deuxi\u00e8me bulletin d\u2019information de CREACT4MED\u00a0\u00bb &#8212; Voisins de l&#039;UE\" data-secret=\"8N1oBnzZf0\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.eumedbridge.eu\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2022\/03\/creaaa.png","thumbnail_width":366,"thumbnail_height":550,"description":"Cette publication est le deuxi\u00e8me bulletin d\u2019information de CREACT4MED. Il s\u2019agit d\u2019une \u00e9dition sp\u00e9ciale qui donne un aper\u00e7u des activit\u00e9s et des r\u00e9alisations du projet entre juillet et d\u00e9cembre 2021. T\u00e9l\u00e9chargement Deuxi\u00e8me bulletin d\u2019information de CREACT4MED"}